日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Anti-FRα Antibody-Drug Conjugate Luveltamab Tazevibulin Demonstrates Efficacy in Non-Small Cell Lung Cancer Preclinical Models and Induces Immunogenic Cell Death.

抗 FRα 抗体药物偶联物 Luveltamab Tazevibulin 在非小细胞肺癌临床前模型中显示出疗效,并诱导免疫原性细胞死亡

Yuan Robert, McGeehan Andrew, Zhou Sihong, Cheng Christine, Armanini Mark, Smith Jennifer, Embry Millicent, Pena Rhoneil, Lewis Danielle K, Hernandez Genevive, Bajjuri Krishna, Tran Cuong, Yin Gang, Abrahams Cristina, Li Xiaofan, Gerber Hans-Peter, Yam Alice, Kiefel Helena

Design of KDM4 Inhibitors with Antiproliferative Effects in Cancer Models

在癌症模型中设计具有抗增殖作用的KDM4抑制剂

Chen, Young K; Bonaldi, Tiziana; Cuomo, Alessandro; Del Rosario, Joselyn R; Hosfield, David J; Kanouni, Toufike; Kao, Shih-Chu; Lai, Chon; Lobo, Neethan A; Matuszkiewicz, Jennifer; McGeehan, Andrew; O'Connell, Shawn M; Shi, Lihong; Stafford, Jeffrey A; Stansfield, Ryan K; Veal, James M; Weiss, Michael S; Yuen, Natalie Y; Wallace, Michael B

Anxiogenic and aversive effects of corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis in the rat: role of CRF receptor subtypes

促肾上腺皮质激素释放因子(CRF)在大鼠终纹床核中的致焦虑和厌恶效应:CRF受体亚型的作用

Sahuque, Lacey L; Kullberg, Erika F; Mcgeehan, Andrew J; Kinder, Jennifer R; Hicks, Megan P; Blanton, Mary G; Janak, Patricia H; Olive, M Foster